Business Context and Reporting Period
This Form 8-K is a current report filed by Onconova Therapeutics, Inc. (noted as Traws Pharma in metadata) on May 22, 2014. The filing documents the results of the Company's 2014 Annual Meeting of Stockholders held on that date.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results.
Material Changes and Voting Results
The following proposals were submitted to a vote of security holders:
- Election of Directors: Stockholders elected seven nominees to serve one-year terms expiring at the 2015 Annual Meeting. All nominees received majority support.
- Ratification of Auditors: Stockholders approved the selection of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ended December 31, 2014.
| Proposal | For | Against/Withheld | Abstain/Non-Votes |
|---|---|---|---|
| Ratify Ernst & Young LLP | 17,893,162 | 128,698 | 26,386 |
| Election of Directors (Total For Votes) | ~84.2 Million | ~3.2 Million | 38.9 Million (Broker Non-Votes) |
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Investor Verification Checklist
- Verify the full list of elected directors and their specific vote counts in the Company's proxy statement.
- Confirm the engagement letter terms with Ernst & Young LLP for the 2014 fiscal year.
- Review the Company's most recent 10-K or 10-Q for financial performance data, as this 8-K contains no financial metrics.